Insider trades
Stock that executives, directors and 10% owners bought and sold on the open market, from the Form 4s they file with the SEC within two business days. Grants, option exercises and shares sold to cover taxes are left out.
- $1.4B bought by 330 insiders at 211 companies
- $6.3B sold by 306 insiders outside a trading plan
- $3.3B sold by 659 insiders under 10b5-1 plans
- 10 companies where two or more insiders bought (30 days)
Biggest buys
Past 3 months · by insider, all their filings added up
-
LENLennar CorporationBerkshire Hathaway Inc.10% owner · +1 joint filer$595M
-
KODKodiak Sciences IncBaker Bros. Advisors LPDirector · +5 joint filers$157M
-
CRBGCorebridge Financial Inc.Life Insurance Co Nippon10% owner$131M
-
GPIGroup 1 Automotive, Inc.Conifer Management, L.L.C.10% owner$115M
-
UUUUniversal Safety Products, Inc.Milton C Ault IIIDirector$92.5M
-
GMEGameStop CorporationRyan CohenCEO$54M
-
GRABGrab Holdings LimitedAnthony Ping Yeow TanCEO$29.9M
-
GSATGlobalstar, Inc.James Monroe IIIDirector$29.8M
-
COURCoursera, Inc.Pale Fire Capital SE10% owner · +4 joint filers$11.4M
-
BORRBorr Drilling LimitedTor Olav TroimDirector$11.2M
Biggest sales
Past 3 months · by insider, all their filings added up · planned sales marked
-
FANGDiamondback Energy, Inc.SGF FANG Holdings, LP10% owner · +1 joint filer$3.7B
-
IHTInnSuites Hospitality TrustMarc E BergEVP & Secretary/Treasurer$361M
-
NVDANvidia Corporation ComMark A StevensDirector$300M
-
AVGOBroadcom Inc.Henry SamueliDirector$250M
-
UMCUnited Microelectronics CorporationChitung LiuCFO$229M
-
THTarget Hospitality Corp.TDR Capital II Investments LP10% owner · +9 joint filers$202M
-
AURAurora Innovation, Inc.Uber Technologies, Inc10% owner$182M
-
ESTCElastic N.V.Steven SchuurmanDirector$135M
-
CRWDCrowdStrike Holdings, Inc.Burt W. PodbereCFO$134M
-
MEDPMedpace Holdings, Inc.August J. TroendleCEO$126M
Cluster buying
Companies where two or more insiders bought on the open market in the last 30 days · most buyers first
-
Reuben S Leibowitz Director, Larry C Glasscock Director, Daniel C. Smith Director, Gary M Rodkin Director, +7 more
-
Milena Maria Pappa Director, Raffaele Zagari Director, Symeon Spyrou CFO, Nikolaos Reskos COO, +3 more
-
Daniel L Florness Director, Srilata Zaheer Director, Charles T Lauber Director, Trangsrud Teresa J Rasmussen Director, +3 more
-
Matthew G De Soto Director, Albert J. Evans Director, Rory G Ritrievi CEO, Joel L. Frank Director, +2 more
-
Avenue RP Opportunities Fund, L.P. 10% owner, Par Chadha Director, Avenue Global Opportunities Master Fund LP 10% owner, Andrej Jonovic CEO, +1 more
-
Thomas Jon Hammond Director, Sandip I Patel CFO, John Martin Schaible Chair, David Craig Ridenhour President, +1 more
-
John B Williamson III Director, Robert B Johnston Director, Paul W Nester CEO, Lawrence T. Oliver Senior VP and Secretary, +1 more
-
Joseph D Sarafa Director, Brian J Roney CEO, Isolde O'Hanlon Director, Harold J Meloche CFO
-
Lewis H Titterton Jr. Director, Amit Kumar CEO, Michael Catelani CFO, Arnold M Baskies Director
-
James A Mitarotonda Director, Chan Galbato Director, John Everets Director, Peggy Scott Director
All insider trades
Newest filings first · one row per filing · every open-market buy and sale
-
Daniel J Rizzo EVP, Sales, Consulting, & SvcsVEEVVeeva Systems Inc.Sale$1.3M 4,841 shares at $276.51 39% of stakeTraded Oct 2 Filed Oct 5
-
Andrew Houston CEODBXDropbox, Inc.Planned sale$12M 354,300 shares at $34.01 100% of stakeTraded Oct 1 Filed Oct 5
-
Martine A Rothblatt CEOUTHRUnited Therapeutics CorporationPlanned sale$5.2M 9,500 shares at $549.37 2.8% of stakeTraded Oct 2 Filed Oct 5
-
Dominic Phillips See RemarksIOTSamsara Inc.Planned sale$1.2M 29,972 shares at $38.97Traded Oct 1 Filed Oct 5
-
Life Insurance Co Nippon 10% ownerCRBGCorebridge Financial Inc.Buy$9M 272,208 shares at $33.07 +0.2% to stakeTraded Oct 1 Filed Oct 5
-
K Charles Janac CEOAIPArteris, Inc.Planned sale$2.4M 100,000 shares at $23.82 1.2% of stakeTraded Oct 1 Filed Oct 5
-
Vincent Roche CEOADIAnalog Devices, Inc.Planned sale$4M 10,000 shares at $396.94 8% of stakeTraded Oct 1 Filed Oct 5
-
David A Duffield 10% ownerWDAYWorkday, Inc.Planned sale$18.4M 98,446 shares at $187.07 48% of stakeTraded Oct 1 Filed Oct 5
-
Bruce C Cozadd DirectorJAZZJazz Pharmaceuticals plcPlanned sale$1.4M 6,000 shares at $230.33 1.7% of stakeTraded Oct 1 Filed Oct 5
-
Rory P Read CEOCXMSprinklr, Inc.Planned sale$1.1M 203,666 shares at $5.17 6.2% of stakeTraded Oct 1 Filed Oct 5
-
Jesse K Bray Pres & CEO, Rocket MortgageRKTRktPlanned sale$1.1M 92,300 shares at $12.39 1.2% of stakeTraded Oct 2 Filed Oct 5
-
George Raymond Zage III DirectorGRNDGrindr Inc.Planned sale$6.9M 500,000 shares at $13.87 6.6% of stakeTraded Oct 1–2 Filed Oct 5
-
William L Meaney CEOIRMIron Mountain IncorporatedPlanned sale$4.2M 38,474 shares at $110.45 100% of stakeTraded Oct 1 Filed Oct 5
-
Matthew Paul Duffy President & Chief Risk OfficerNPNeptune Insurance Holdings Inc.Planned sale$1.1M 39,737 shares at $27.67 1.9% of stakeTraded Oct 2 Filed Oct 5
-
Japan Post Holdings Co., Ltd. 10% ownerAFLAflac IncorporatedPlanned sale$1.3M 11,900 shares at $111.18 <0.1% of stakeTraded Oct 1 Filed Oct 5
-
Caroline Cochran COOOKLOOklo Inc.Planned sale$4.4M 120,000 shares at $36.51Traded Oct 1 Filed Oct 5
-
Hershey Trust Co. Trustee In Trust For Milton Hershey School 10% ownerHSYHershey Company (The)Planned sale$3.2M 20,000 shares at $159.56 2.9% of stakeTraded Oct 1–2 Filed Oct 5
-
Kurt James Wolf CEOPBIPitney Bowes Inc.Planned sale$2.4M 150,000 shares at $16.16 62% of stakeTraded Oct 1 Filed Oct 5
-
Patrizio Vinciarelli CEOVICRVicor CorporationPlanned sale$6.2M 20,000 shares at $310.12 0.2% of stakeTraded Oct 2 Filed Oct 5
-
Patrizio Vinciarelli CEOVICRVicor CorporationPlanned sale$6.3M 20,000 shares at $316.13 0.2% of stakeTraded Oct 1 Filed Oct 5
-
Feng Zhao President of GarenaSESea LimitedPlanned sale$3.8M 40,000 shares at $95.02 30% of stakeTraded Oct 1 Filed Oct 5
-
Solomon Moshkevich President, ClinicaldiagnosticsNTRANatera, Inc.Planned sale$1.2M 3,000 shares at $414.22 2.7% of stakeTraded Oct 1 Filed Oct 2
-
Michael Sentonas PresidentCRWDCrowdStrike Holdings, Inc.Planned sale$64.2M 241,944 shares at $265.45 16% of stakeTraded Sep 30 Filed Oct 2
-
Heidy King-Jones See RemarksSYRESpyre Therapeutics, Inc.Planned sale$2.6M 28,933 shares at $91.03 91% of stakeTraded Oct 1 Filed Oct 2
-
Cameron Turtle CEOSYRESpyre Therapeutics, Inc.Planned sale$1.4M 15,000 shares at $92.01 2.7% of stakeTraded Oct 1 Filed Oct 2
-
Scott L Burrows CFOSYRESpyre Therapeutics, Inc.Planned sale$2.3M 25,000 shares at $90.47 24% of stakeTraded Sep 30–Oct 1 Filed Oct 2
-
Johannes Jacob Pieter Kastelein Chief Scientific OfficerNAMSNewAmsterdam Pharma Company N.V.Planned sale$1.3M 50,246 shares at $25.03 42% of stakeTraded Sep 30 Filed Oct 2
-
Life Insurance Co Nippon 10% ownerCRBGCorebridge Financial Inc.Buy$11.7M 348,215 shares at $33.65 +0.3% to stakeTraded Sep 30 Filed Oct 2
-
Ryan McInerney CEOVVisa Inc-Class A ShrsPlanned sale$2.1M 5,875 shares at $358.81 28% of stakeTraded Oct 1 Filed Oct 2
-
Jesse K Bray Pres & CEO, Rocket MortgageRKTRktPlanned sale$1.6M 132,700 shares at $12.01 1.7% of stakeTraded Oct 1 Filed Oct 2
-
Scott Jeffrey Klum 10% ownerROCRank One Computing CorporationSale$4.1M 1,200,000 shares at $3.42 41% of stakeTraded Sep 30 Filed Oct 2
-
Bernard Shek Chief Legal Officer and SectySNDKSandisk Corp.Planned sale$1M 600 shares at $1,734.94 2.3% of stakeTraded Oct 1 Filed Oct 2
-
Michael L Speiser DirectorSNOWSnowflake Inc.Planned sale$17.5M 50,741 shares at $344.00Traded Oct 2 Filed Oct 2
-
Christian Kleinerman EVP, Product ManagementSNOWSnowflake Inc.Planned sale$5.1M 15,000 shares at $341.57 4.6% of stakeTraded Oct 1 Filed Oct 2
-
Allan C. Thygesen CEODOCUDocuSign, Inc.Planned sale$1.8M 26,250 shares at $69.29 14% of stakeTraded Oct 1 Filed Oct 2
-
Lawrence Otto Klein CEOORKAOruka Therapeutics, Inc.Planned sale$2.1M 25,000 shares at $83.62 2.6% of stakeTraded Oct 1 Filed Oct 2
-
Foundation Fighting Blindness Retinal Degeneration Fund Director · +1 joint filerIRDOpus Genetics, Inc.Sale$2.8M 556,000 shares at $4.96 15% of stakeTraded Sep 30 Filed Oct 2
-
Randolph Altschuler DirectorXMTRXometry, Inc.Planned sale$1M 10,000 shares at $104.04 1.8% of stakeTraded Oct 1 Filed Oct 2
-
George Kurtz CEOCRWDCrowdStrike Holdings, Inc.Planned sale$5.3M 20,000 shares at $265.46 0.3% of stakeTraded Sep 30–Oct 1 Filed Oct 2
-
Jon Congleton CEOMLYSMineralys Therapeutics, Inc.Planned sale$1.9M 75,000 shares at $25.46 12% of stakeTraded Sep 30 Filed Oct 2
-
John Wendell Thompson DirectorRBRKRubrik, Inc.Planned sale$1.6M 13,500 shares at $115.69Traded Oct 1 Filed Oct 2
-
Scott Bender CEOWHDCactus, Inc.Planned sale$6.2M 100,000 shares at $61.97 45% of stakeTraded Oct 1 Filed Oct 2
-
Eric Venker CEOROIVRoivant Sciences Ltd.Planned sale$7.3M 200,000 shares at $36.62 11% of stakeTraded Sep 30 Filed Oct 2
-
Adam C. Spice CFORKLBRocket Lab CorporationPlanned sale$9.9M 140,157 shares at $70.82 11% of stakeTraded Oct 1 Filed Oct 2
-
Aaron Jagdfeld CEOGNRCGenerac Holdings Inc.Planned sale$1M 5,000 shares at $206.00 0.9% of stakeTraded Oct 1 Filed Oct 2
-
Neil Harris Blumenthal CEOWRBYWarby Parker Inc.Planned sale$2.8M 100,000 shares at $27.69 74% of stakeTraded Oct 1 Filed Oct 2
-
Aman Joshi Chief Commercial OfficerBEBloom Energy CorporationPlanned sale$2.3M 8,437 shares at $277.17 5.4% of stakeTraded Oct 1 Filed Oct 2
About this data
- Officers, directors and anyone owning more than 10% of a company must report a trade in its stock on a Form 4 within two business days. We read each filing from SEC EDGAR and link to it on every row.
- Only open-market purchases and sales of common stock count here. Stock grants, option exercises, gifts and shares withheld or sold to pay taxes on vesting awards are not decisions to buy or sell, so they are left out.
- A planned sale was made under a Rule 10b5-1 trading plan, which the insider set up months in advance. Many executives sell this way on a schedule, so a planned sale says less than one made on the day.
- Values are shares times the price reported. When a filing amends an earlier one, the amended trades replace the originals. Related owners (a fund and its manager) who report the same trade separately are shown once.
- We cover the 4,792 US companies on our earnings calendar, with a year of history. The superinvestor notes count the featured 13F managers who added or cut the stock in their latest quarter.